MoneyWorks4Me

The Sales for the quarter ended June 2026 of Rs. 5.44 million declined by -66.75% from Rs. 16.36 millions.Net profit was down at Rs. 0.31  millions against Rs. 68.85 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -99.55%.Operating profit for the quarter ended June 2026 decreased to 4.77 millions as compared to 69.77 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 5.44 16.36 -66.75 5.44 16.36 -66.75 39.44 40.39 -2.35
Other Income 16.97 81.71 -79.23 16.97 81.71 -79.23 155.74 152.95 1.82
PBIDT 4.77 69.77 -93.16 4.77 69.77 -93.16 104.49 79.67 31.15
Interest 1.71 0.64 167.19 1.71 0.64 167.19 4.04 3.40 18.82
PBDT 3.06 69.13 -95.57 3.06 69.13 -95.57 100.45 81.80 22.80
Depreciation 0.19 0.24 -20.83 0.19 0.24 -20.83 0.95 1.03 -7.77
PBT 2.87 68.89 -95.83 2.87 68.89 -95.83 99.50 80.77 23.19
TAX 2.56 0.04 6300.00 2.56 0.04 6300.00 -10.41 -1.64 534.76
Deferred Tax 0.00 0.04 0.00 0.00 0.04 0.00 1.27 -1.64 -177.44
PAT 0.31 68.85 -99.55 0.31 68.85 -99.55 109.91 82.41 33.37
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 87.68 426.47 -79.44 87.68 426.47 -79.44 264.93 197.25 34.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..